Synthroid 137 MCG tablet 1000S
Ended Awarded
- Contract number
- SPE2DB25FVJGY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,325
Award facts
- Contract value 100% obligated
- $88,324.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $88,324.54 to AmerisourceBergen Drug Corp for the supply of Synthroid 137 mcg tablets in quantities of 1,000 units. This firm fixed-price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through open competition without set-aside provisions to fulfill this medical supply requirement. The company's extensive portfolio of federal contracts with the Defense Logistics Agency and its Medical Supply Chain demonstrates its capability to reliably deliver a wide range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for Synthroid, a thyroid hormone replacement medication commonly used in military healthcare settings, exemplifies the company's role as a critical vendor in the federal medical procurement supply chain.
Quick answers
Who was awarded contract SPE2DB25FVJGY?
SPE2DB25FVJGY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FVJGY worth?
The government has obligated $88,325 on SPE2DB25FVJGY.
Is contract SPE2DB25FVJGY an order under another contract?
Yes. SPE2DB25FVJGY is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVJGY competed?
The extent of competition for SPE2DB25FVJGY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award